Bausch Health falls on phase 3 failure of liver disease complications drug
2026-01-23 08:55:07 ET
More on Bausch Health Companies
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript
- Bausch Health sets 2025 outlook at the higher end of the prior range
- Carl Icahn's top Q3 moves include new stake in EchoStar, exiting Bausch Health
Read the full article on Seeking Alpha
For further details see:
Bausch Health falls on phase 3 failure of liver disease complications drugNASDAQ: HE
HE Trading
-5.14% G/L:
$14.76 Last:
1,463,005 Volume:
$15.43 Open:



